母乳养及其对高危新生儿血糖趋势和低血糖风险的影响:前性观察研究
Daniel Chan1,2,3, Suresh Chandran2,3,4, Mei Chien Chua2,3,4
1Endocrinology Service, KK Women's and Children's Hospital, Singapore, Singapore.
Journal of paediatrics and child health
|September 4, 2025
概括
新生儿低血糖的风险与母乳养婴儿相似,尽管母乳养婴儿的葡萄糖水平较低. 这些发现支持对有风险的新生儿进行母乳养.
科学领域:
- 新生儿生理学
- 儿童营养
- 内分泌学
背景情况:
- 新生儿血糖调节在出生后迅速转变,有风险的婴儿面临低血糖症.
- 早期养至关重要,但养类型对葡萄糖平衡的影响尚不清楚.
研究的目的:
- 为了比较纯母乳养和配方奶粉养的风险新生儿的葡萄糖轨迹和低血糖发生率.
主要方法:
- 对192名处于风险中的新生儿进行前性观察队列研究.
- 血糖测量时间为2,6,12,18和24小时.
- 低血糖定义为<3.0 mmol/L;用于评估风险的逻辑回归.
主要成果:
- 配方奶粉养的新生儿在6小时,12小时和24小时的血糖水平较高 (p<0.05).
- 在配方奶粉的婴儿中,累积葡萄糖暴露率 (AUC) 较高 (85. 1 mmol/ L- hour).
- 整体低血糖发生率 (< 3.0 mmol/ L) 在各组之间是相似的 (14. 7% 对比 11. 1%, p=0. 615).
结论:
- 哺乳新生儿的葡萄糖水平较低,但低血糖的风险与配方奶粉新生儿相比较.
- 这些发现支持优先授乳危险新生儿.
- 需要对养方式的长期代谢结果进行进一步研究.
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Glucose Homeostasis: Regulation of Blood Glucose
2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288


